Upstream Bioprocessing 2021

Vectors

Upstream Bioprocessing 2021

Transfer and scale-up from 10 L BioBLU®️ to Allegro™ STR 50 and STR 200 Bioreactors

Transfer and scale-up from 10 L BioBLU®️ to Allegro™ STR 50 and STR 200 Bioreactors

D Mainwaring, A Joshi, J Coronel et al

25 November 2021

Innovator Insight

Development of a scalable AAV production process in suspension cells

Development of a scalable AAV production process in suspension cells

Ann-Christin Magnusson

11 November 2021

Key considerations for maximizing LV and AAV production in transient transfection workflows

Key considerations for maximizing LV and AAV production in transient transfection workflows

L Kopp, B Larimore, N Sutherland et al

08 October 2021

Innovator Insight

Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies

Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies

05 October 2021

Achieving cost-effective, scalable high-titer AAV production

Achieving cost-effective, scalable high-titer AAV production

30 September 2021

Addressing HEK293 cell lineage and AAV diversity with media panel

Addressing HEK293 cell lineage and AAV diversity with media panel

Jennifer A Schieber

29 September 2021

Utilizing a media panel rapidly accelerates media optimization for AAV manufacturers

Utilizing a media panel rapidly accelerates media optimization for AAV manufacturers

Céline Martin, Jennifer Zatina

28 September 2021

Innovator Insight

Overview of major AAV production platforms

Overview of major AAV production platforms

24 September 2021

Scalability comparison between 50 and 500 liter stirred tank bioreactor for production of rAAV viral vector

Scalability comparison between 50 and 500 liter stirred tank bioreactor for production of rAAV viral vector

T P Sanderson, T Erlandson, N Hazi et al

23 September 2021

Innovator Insight

1
2
>
>>

<< Back to Vectors channel